Καλώς ήρθατε στο Ιατρικό Τμήμα της AstraZeneca

Privacy Notice and Consent for Champion site (AE, MI and PQC)

AstraZeneca (the company) would like to respond to your requests regarding AE reporting, MI (medical information inquiry), and PQC (product quality compliant) through the CHAMPion site, an integrated customer request processing site.

The items of personal information required for each report and inquiry, purpose of processing and retention period are as follows. Please take a close look and show your agree on each consents below.

Please note that you may not agree to the collection and use of personal information requested on this site, but if you do not agree, we may not be able to respond to your request.

Consent to collect and use personal information

Adverse Event

Purpose of collection and use: Collects abnormal case information and reports to the regulatory authorities and headquarters as a post marketing safety management.

Information to collection and use: Name (if necessary), date of birth, gender, height, weight, contact information (if selected), occupation. (to find whether HCP or not).

Retention period: 15 years after the end of the item license.

Medical Information

Purpose of collection and use: Reply to your medical information inquiries.

Information to collection and use: Name, contact information (phone number or mobile phone number), E-mail (if necessary), and Occupation (for the purpose of verifying health care professionals).

Retention period: 6 years from the date of consent.

Product Quality Complaint

Purpose of collection and use: Receiving complaints of AZ products, sending new product as an exchange and reply with investigation reports.

Information to collection and use: Name, Contact information (phone number or mobile phone number), Work address and email address (if necessary).

Retention period: Up to 6 years from the date of consent.

Consent to sensitive information

AZ wishes to collect, use and provide your sensitive information as follows, Information to collect and use: Health status, drug use, treatment information, drug administration information, experienced abnormal case information, pregnancy-related information (if selected), medical personnel/caregiver information (if selected).

Purpose of use: Collection of abnormal case information and reporting to the regulatory authority/head office.

Consent to disclosure of personal information to a third party

The company may provide personal information and sensitive information collected as above to regulatory authorities (Ministry of Food and Drug Safety Korea, Korea Pharmaceutical Safety Management Agency) and overseas headquarters in order to comply with the drug surveillance obligations under laws and regulations.

Personal information and sensitive information collected and used according to your consent and voluntary provision are managed in accordance with the AZ Global Privacy Policy and AstraZeneca Korea’s personal information processing policy. You can find them with the links below.   https://www.globalprivacy.astrazeneca.com/   https://www.astrazeneca.co.kr/privacy-notice/